Abstract bekijken

Deze abstract is toegekend aan sessie Poster session in O'Bistro
TitelVisual Function after Gene Therapy for RPE65-Related LCA
DoelTo describe changes in visual function after gene therapy for RPE65-related Leber congenital amaurosis.
MethodesTwo male Belgian patients of 9 and 10 years old at the first treatment underwent an extensive ophthalmological work-up, including psychophysical testing. Here, we focused on best-corrected visual acuity (BCVA), Goldmann visual fields (GVF) and a Low Vision Panel D-15 colour vision test. Both patients were treated with consecutive vitrectomies with a subretinal injection of AAV2-hRPE65v2 ((4,8x1010 and 1,5x1010 vector genomes in 1st and 2nd eyes respectively).
ResultatenBoth patients showed a significant bilateral improvement of BCVA after treatment of the first eye, but BCVA did not significantly change after treatment of the second eye. A clear improvement in GVF of both eyes was noted after treatment of the first eye, with further improvement of both GVFs, after the second eye was treated. Colour vision did not improve significantly following gene therapy.
ConclusieGene therapy with subretinal injection of AAV2-hRPE65v2 is a safe procedure, but also significantly improves retinal sensitivity and consequently visual function. This is most clearly illustrated by the improved GVF.
Auteur 1
NaamUVIJLS
InitialenA
InstituutDept Ophth, GUH
StadGhent
Auteur 2
NaamMaguire
InitialenAM
InstituutFM Kirby Center for Mol Ophth, Penn
StadPhiladelphia
Auteur 3
NaamHigh
InitialenKA
InstituutCtr Cell Mol Therapeutics, CHOP
StadPhiladelphia
Auteur 4
NaamWright
InitialenJF
InstituutCtr Cell Mol Therapeutics, CHOP
StadPhiladelphia
Auteur 5
NaamPierce
InitialenEA
InstituutFM Kirby Center for Mol Ophth, Penn
StadPhiladelphia
Auteur 6
NaamDe Baere
InitialenE
InstituutCtr for Med Genet, GUH
StadGhent
Auteur 7
NaamMarshall
InitialenKA
InstituutCtr Cell Mol Therapeutics, CHOP
StadPhiladelphia
Auteur 8
NaamChung
InitialenDC
InstituutFM Kirby Center for Mol Ophth, Penn
StadPhiladelphia
Auteur 9
NaamSun
InitialenJ
InstituutCtr Cell Mol Therapeutics, CHOP
StadPhiladelphia
Auteur 10
NaamMcDonnell
InitialenJ
InstituutCtr Cell Mol Therapeutics, CHOP
StadPhiladelphia
Auteur 11
NaamBennett
InitialenJ
InstituutFM Kirby Center for Mol Ophth, Penn
StadPhiladelphia
Auteur 12
NaamLeroy
InitialenBP
InstituutDept Ophth & Ctr Med Genet, GUH
StadGhent
top ^